These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8513497)

  • 21. Impaired development of CD4+ CD8+ thymoyctes by csk-'knock-in' into fyn locus.
    Kanazawa S; Ilic D; Hashiyama M; Okada M; Noumura T; Aizawa S; Suda T
    Oncogene; 1996 Jul; 13(1):199-204. PubMed ID: 8700547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk).
    Schmedt C; Tarakhovsky A
    J Exp Med; 2001 Apr; 193(7):815-26. PubMed ID: 11283154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
    Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
    Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src family kinases are required for integrin but not PDGFR signal transduction.
    Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
    EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk.
    Kuo SS; Moran P; Gripp J; Armanini M; Phillips HS; Goddard A; Caras IW
    J Neurosci Res; 1994 Aug; 38(6):705-15. PubMed ID: 7807586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.
    Suzuki T; Kono H; Hirose N; Okada M; Yamamoto T; Yamamoto K; Honda Z
    J Immunol; 2000 Jul; 165(1):473-82. PubMed ID: 10861086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Csk in neural differentiation of the embryonic carcinoma cell line P19.
    Takayama Y; Nada S; Nagai K; Okada M
    FEBS Lett; 1997 Apr; 406(1-2):11-6. PubMed ID: 9109376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Csk regulates integrin-mediated signals: involvement of differential activation of ERK and Akt.
    Gu J; Nada S; Okada M; Sekiguchi K
    Biochem Biophys Res Commun; 2003 Apr; 303(3):973-7. PubMed ID: 12670507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.
    Ruzzene M; Songyang Z; Marin O; Donella-Deana A; Brunati AM; Guerra B; Agostinis P; Cantley LC; Pinna LA
    Eur J Biochem; 1997 Jun; 246(2):433-9. PubMed ID: 9208935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p50 C-terminal Src kinase (Csk) in mouse testis.
    Gye MC; Choi JK; Ahn HS; Kim YS
    Arch Androl; 2004; 50(4):287-93. PubMed ID: 15277007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
    Huang WC; Chen JJ; Inoue H; Chen CC
    J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.